Glucotrol Articles
Japan stock market week to June 8, 2009
9 June 2009
GSK reports lack of CV AEs in Avandia study
24 November 2008
Januvia lowers hypoglycemia risk vs glipizide
16 June 2008
Final FDA appro for Caraco's generic Metaglip
21 January 2008
sNDA for Merck & Co's Januvia OKed
22 October 2007
Final FDA OK for Mylan's generic of B-MS' Metaglip
23 April 2007
Strong data on Merck & Co's Janumet
18 December 2006
Banyu/Ono start Ph III trial of sitagliptin
14 August 2006
Merck & Co's Januiva: 'non-inferior to metformin'
13 June 2006
Andrx' 4th-qtr 2005 income drops 16%
27 March 2006
India's Supreme Court OKs NNPA price orders
18 April 2005
Watson revenues in 2003 hit record $1.46B
16 February 2004
Watson gains final FDA OK for generic Glucotrol XL 10mg
17 November 2003
Stock Commentary - New York
17 November 2003
Watson buys research unit from Amarin
3 November 2003
India's NPPA seeks to recover millions of rupees from 50 local companies
15 September 2003
Strong 4th-quarter operating results at Merck KGaA on flat sales
24 February 2003
FDA filings in brief
6 January 2003
Court frees 7 drugs from India's DPCO
3 September 2001
ICAgen To Start Trials Of Three Drugs In 1999
25 November 1998
Benefits Of Pfizer's Glucotrol XL Reported In Diabetes Study
6 November 1998
UKPDS - Implications For Type 2 Diabetes Treatment
17 September 1998
Latest Wave Of US 1st Quarter Results
7 May 1998
Trend For 1997 Strong Sales Continues In USA
5 February 1998
SkyePharma In Cash Crisis As Losses Double
18 September 1997
Pfizer Gets AAA Ranking From S&P
12 June 1997
Strong Earnings Continue At Major US Drug Firms
10 February 1997
Major US Drug Cos Post Strong Results In 3rd Qtr
28 October 1996
US Drug Majors See 2nd-Half Double-Digit Growth
29 July 1996
US Firms' Strong 1st Qtr Lifts Share Prices
29 April 1996
Mixed Results For Q4 1995 From US Drug Majors
29 January 1996
Ivax gets approval for glipizide
11 September 1995
US Economic Slowdown Affects Larger Firms
7 August 1995
Watson Offers $606.5 Million For Circa
10 April 1995
Black & Edgington Enters Generic Market
3 April 1995
Watson Labs Receives US Approval
20 March 1995
Alza, Pfizer Copromote Glucotrol XL
31 October 1994
Generic Drug Stocks - A Buying Opportunity
22 August 1994
PFIZER MAKES $100 MILL DEAL WITH VALUE HEALTH
16 May 1994
MYLAN APPROVAL IN USA
16 May 1994
PFIZER'S GLUCOTROL XL LAUNCHED IN USA
9 May 1994
PFIZER'S "CONTINUING SUCCESS"
11 April 1994
ACTISITE CLEARED FOR MARKET IN USA
11 April 1994
WORLD ENDOCRINE MARKET AND FORECASTS
29 March 1993
PFIZER TO FILE NDA FOR DIABETES DRUG
14 December 1992
Showing 1-60 of 60 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
